S&S Insider reported that the U.S. central venous catheter market is projected to hit USD 1.09 billion by 2032 as demand for oncology, dialysis, and ICU procedures accelerates.Austin, Sept. 30, 2025 ...

The global catheter stabilization devices market is expected to grow at a CAGR of ~6% during the forecast period. The market ...

U.S. hospitals and specialty clinics drive strong adoption of NICU catheters, while Asia Pacific emerges as the fastest-growing region.Austin, Oct. 01, 2025 (GLOBE NEWSWIRE) -- NICU Catheters Market ...

There's more to rattan than wicker. Designers are finding new ways of shaping the vine material into furniture with a lower ...

Central venous access devices (CVADs) are thin, flexible tubes inserted into large veins to deliver essential medications and fluids directly into the ...

Xeltis has announced successful results from its aXess EU phase 3 trial, confirming the potential of its restorative vascular ...

Combination reduced the risk of disease progression or death by 46% and risk of death by 27% in pivotal Phase 3 IMforte trial Zepzelca and atezolizumab ...

The vascular access device market is experiencing a steady growth rate with a CAGR of ~6% during the forecast period. The ...

Each year, more than 2.2 million children around the world undergo central venous access procedures, with a thin, flexible ...

In a guidance document issued by the Society of Interventional Radiology Practice and published online Sept. 9 in the Journal ...

CorMedix CRMD has taken a major step toward diversifying its revenue base and reducing reliance on a single product with the recent $300 million acquisition of Melinta Therapeutics. The move ...